Morepen Laboratories Limited

NSE MOREPENLAB.NS

Morepen Laboratories Limited Shares (Diluted, Weighted) for the year ending March 31, 2024: 511,168,708

Morepen Laboratories Limited Shares (Diluted, Weighted) is 511,168,708 for the year ending March 31, 2024, a 1.78% change year over year. Shares (diluted, weighted) are the number of outstanding shares used to calculate earnings per share (EPS) assuming the conversion of all potentially dilutive securities.

Morepen Laboratories Limited Shares (Diluted, Weighted) for the year ending March 31, 2023 was 502,206,570, a -3.39% change year over year.
Morepen Laboratories Limited Shares (Diluted, Weighted) for the year ending March 31, 2022 was 519,826,202, a 15.24% change year over year.
Morepen Laboratories Limited Shares (Diluted, Weighted) for the year ending March 31, 2021 was 451,072,778, a 0.28% change year over year.
Morepen Laboratories Limited Shares (Diluted, Weighted) for the year ending March 31, 2020 was 449,826,203, a 0.00% change year over year.

Key data

Date	Shares (Diluted, Weighted)	Revenue	Cost of Revenue	Gross Profit

NSE: MOREPENLAB.NS

Morepen Laboratories Limited

CEO	Mr. Sushil Suri B.Sc., F.C.A., FCA
IPO Date	Jan. 1, 1996
Location	India
Headquarters	409, Antriksh Bhawan
Employees	2,152
Sector	Health Care
Industries Pharmaceuticals

Description

Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), branded and generic formulations, and home health products in India. The company offers APIs for anti-histaminic, anti-asthmatic, anti-hypercholesterolemic, anti-hypertensive, and anti-diabetic drugs; point of care and medical devices; and home diagnostic products, such as air purifiers, thermometers, stethoscopes, blood pressure monitors, pulse-oximeters, nebulizers, glucometers, strips, sanitizers, disinfectant solutions, masks and gloves, and others. It also provides Burnol, a burn cream; Lemolate for cough and cold; and Fiber-X, a sat isabgol; and formulations for gastro, antibiotics, vitamins, nutritional, and anti-diabetics, as well as cardiac. In addition, the company is involved in the product contract manufacturing and brand sharing businesses; and provision of over-the-counter products under the Dr. Morepen brand. It exports its products to approximately 75 countries. Morepen Laboratories Limited was incorporated in 1984 and is based in New Delhi, India.

Key trends

Past 5 years